A lyophilised synthetic peptide is a salt. The peptide carries positive charges; something negative accompanies it into the dried solid; and in the great majority of commercially prepared material that something is trifluoroacetate. It is not an impurity in the ordinary sense — it arrives as an unavoidable consequence of how the peptide was made and purified — but it occupies mass, it can be measured, and the published literature records effects attributable to it. This page describes where it comes from, how much of a vial it accounts for, what has been reported about it in biological work, and what an exchange to acetate changes.
Where trifluoroacetate comes from
It enters at two separate points in the production chain.
The first is cleavage. In Fmoc-based solid-phase synthesis, trifluoroacetic acid serves as the global deprotection and cleavage agent that releases the assembled chain from the resin and removes side-chain protecting groups, in place of the more hazardous hydrofluoric acid used in the older Boc chemistry 1. The same step is described in the antimicrobial peptide literature: amino acid derivatives are added to an elongating chain and the product is released from the resin with a strong acid, most commonly trifluoroacetic acid in Fmoc/tert-butyl chemistry 2.
The second is purification. Trifluoroacetic acid is also the conventional ion-pairing reagent in reversed-phase liquid chromatography, used for both preparative purification and analytical characterisation 1. Its function there is well understood: the anion ion-pairs with positively charged peptide residues, which neutralises those groups and increases the affinity of the peptide for the reversed-phase sorbent 3. The consequence is stated plainly in the synthesis literature — peptides purified by reversed-phase chromatography are obtained as trifluoroacetate salts 2 — and the strong interaction leaves a peptide–trifluoroacetate salt behind when the collected fractions are freeze-dried 1.
How much mass it accounts for
The proportion is larger than is often assumed.
A quantitative study of purified synthetic peptides measured 0.333 ± 0.008 mg of trifluoroacetate per mg of peptide salt in one sequence after purification, with calculated weight fractions across the peptides examined ranging from approximately 21.9% to 35.2% 1. The same work found that the peptides consistently contained trifluoroacetate in excess of the amount that the number of positive charges would predict, so a stoichiometric calculation from the sequence underestimates the true content 1.
That mass is one component of the non-peptide balance that separates the label mass of a vial from the mass of peptide in it. Net peptide content is defined as the amount of actual peptide within a gravimetrically measured sample, explicitly excluding the weight of water and counter-ions 4. In reference-standard characterisation the same balance is enumerated item by item, with all detectable impurities — peptide-related impurities, counter-ion, water and the rest — subtracted from one hundred percent, and with acetic acid and trifluoroacetic acid content reported as separate weight-for-weight figures 5. Reported values in that programme included acetic acid at 5.58% w/w in a material where trifluoroacetic acid was only 0.003% w/w, which is the signature of a peptide supplied as the acetate rather than the trifluoroacetate 5.
The practical consequence is arithmetic. Weighing a lyophilised solid measures the salt, the water and everything else in the cake. Where a quantity of peptide is the variable of interest, the content figure rather than the weighed mass is the number that governs the calculation 4.
Measuring it
Several orthogonal methods have been validated for the determination, and they differ substantially in sensitivity.
Fluorine-19 nuclear magnetic resonance gave excellent precision, with relative standard deviations below 3% across quality-control levels and a limit of quantification of 20.68 µg/mL 1. Liquid chromatography with evaporative light-scattering detection reached a lower limit of quantification of 1.52 µg/mL and allowed simultaneous detection of trifluoroacetate together with chloride and sodium 1. Infrared spectroscopy is usable but much less sensitive: the carbon–fluorine stretch near 1200 cm⁻¹ proved the most suitable band for quantification, yet the method showed high variability and a limit of quantification of 713 µg/mL 1. Ion chromatography is also used for the purpose, though it was not among the methods validated in that comparison 1. In pharmacopoeial reference-standard work the figure appears as a weight-for-weight content on the characterisation record 5.
Reported effects in biological work
The literature records effects in both directions, which is itself the important point.
A 2025 review of the analysis and exchange of the counter-ion summarises that residual trifluoroacetate has been shown to increase, as well as to inhibit, cell proliferation, to increase cell and liver toxicity, and to lead to greater activation of antibody responses 1. The same work examined passive membrane permeation and concluded that counter-ions can modulate it, proposing that peptides may cross membranes as neutral peptide–counter-ion complexes rather than as free cations, with trifluoroacetate shielding the polarity of the peptide; for the angiotensin peptides studied, which did not permeate, the identity of the counter-ion did not alter that outcome 1.
A direct comparison of salt forms of the same antimicrobial peptides is more specific. Across all the peptides examined, the lowest antimicrobial activity was found for the trifluoroacetate salts, with the distribution of minimum inhibitory concentrations for the chloride and acetate forms shifted toward lower concentrations 2. Cytotoxicity results were peptide-dependent rather than uniform: for citropin 1.1, LL-37 and pexiganan the lowest cytotoxicity was found for the acetate salts 2. Haemolysis moved the other way for one peptide, with pexiganan acetate producing 30.75% haemolysis of red blood cells at 256 µg/mL against 7.04% for the trifluoroacetate and 8.51% for the chloride 2.
Taken together, these are not a ranking of salt forms. They are evidence that the counter-ion is a variable in an assay result, and that a comparison between two materials of unstated salt form is confounded.
Exchange to acetate
Exchange is a distinct processing step performed after purification, and it is not free of consequence.
One published procedure removed the trifluoroacetate anions with a carbonate ion-exchange resin, added dilute acetic acid, and lyophilised the samples, yielding the acetate salt 2. The chloride form was obtained in the same study either by lyophilisation from 0.1 M hydrochloric acid or from hydrochloric-acid-saturated acetonitrile 2. A systematic optimisation identified 10 mM hydrochloric acid as the optimal exchange concentration, reducing trifluoroacetate content below the limit of quantification after a single lyophilisation cycle 1.
Because the exchange replaces one anion with another rather than removing the anion, the product remains a salt. What changes is which salt, and therefore what the quoted molecular weight refers to.
Salt form and quoted molecular weight
A molecular weight is a property of a defined substance, and a peptide trifluoroacetate, a peptide acetate and the free peptide are three substances.
The weight fractions above make the size of the discrepancy concrete: where trifluoroacetate accounts for between roughly a fifth and a third of the mass of the dried salt 1, a figure quoted for the free peptide and a figure quoted for the salt cannot be used interchangeably in any calculation that starts from a weighed mass. Reference-standard documentation handles this by reporting the counter-ion content as its own line on the characterisation record, separately from water and from residual solvents 5.
The rule that follows is simple to state. A molecular weight is interpretable only when the salt form it belongs to is stated with it, and a content figure is interpretable only when the counter-ion it excludes is named 4.
Salt form is not a detail of packaging. It changes the mass of the solid, it has documented effects in cell-based assays, and it determines which molecular weight applies. Where a certificate omits it, the vial's composition is partly unknown.